599 results
Prediction of death or HF hospitalization in patients with severe FMR: the COAPT risk score
19 Oct 2022
The new analysis from the COAPT trial indicated that lower secondary mitral regurgitation by TEER was strongly associated with reduced heart failure hospitalization, all-cause mortality, and improved quality of life as compared with a higher degree of residual MR.
Reviewer
Reviewer
Clinical cases - Structural interventions - Session 7
07 Oct 2022 – From AICT-AsiaPCR 2022
Outcome of women in different cardiovascular interventions
06 Oct 2022 – From AICT-AsiaPCR 2022
Mid-term echocardiographic outcomes following transapical mitral valve replacement: Updates from the Intrepid Pilot Study
19 Sep 2022
Pamela Gatto provides her take on the Intrepid Global Pilot Study which was presented by Renuka Jain at TCT Congress 2022.
Author
Transcatheter edge-to-edge repair in patients with severe mitral regurgitation and cardiogenic shock: Insights from the TVT Registry
17 Sep 2022
Mirvat Alasnag provides her take on the TEER Shock study which was presented at TCT 2022 by Mohamad A. Alkhouli.
Author
PCRonline @ TCT 2022 - Get the international perspective!
12 Sep 2022
Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2022 - check out the list here!
Structural Heart Disease pre-case planning tutorials: Mitral valve TMVR
08 Sep 2022
In this series of tutorials, Gilbert Tang proposes instruction videos on how to use 3mensio for pre-case planning in Mitral Valve-in-Valve TMVR.
Relative survival after mitral TEER in MitraSwiss patients
28 Aug 2022
Mirvat Alasnag interviews Luigi Biasco, first author of the MitraSwiss Registry which was presented at the ESC Congress 2022 in Barcelona. Together, they discuss the enrolled population, the inclusion criteria, the design and outcomes of MitraSwiss, its comparison with other European registries and the restoration of...
Author
Author
The PASCAL IID Registry: A prospective registry for transcatheter edge-to-edge repair in prohibitive risk patients with degenerative mitral regurgitation and complex mitral valve anatomy
17 Sep 2022
Alex Sticchi provides his take on the PASCAL IID Registry and an initial comparison with the CLASP IID. The trial was presented by Jörg Hausleiter during TCT Congress 2022.
Author
CLASP II D: A randomized comparison of TEER devices for degenerative mitral regurgitation
20 Sep 2022
Luigi Biasco interviews Scott Lim and Konstantinos P. Koulogiannis, Principal Investigators of CLASP IID.
The trial demonstrated safety and effectiveness of the PASCAL system and met non-inferiority endpoints, expanding transcatheter treatment options for prohibitive surgical risk patients with significant symptomatic degenerative mitral regurgitation.
Author
Author
Author
